Nanoparticles Yield Safer Light-Activated Cancer Therapy

September 27, 2007

Photodynamic therapy, in which light activates a chemical known as a photosensitizer, triggering the production of cell-killing reactive oxygen, has proven itself as an effective therapy for a limited number of cancers.

Oncologists have long suspected that photodynamic therapy could find broader use if only there was some way to limit the accumulation of photosensitizer molecules to tumors, sparing healthy tissue from unintended damage. Now, using modified silica nanoparticles, a team of investigators at the State University of New York, Buffalo, has developed a photosensitizer delivery method that has the potential to target tumor cells specifically.

Paras Prasad, Ph.D., principal investigator of one of the National Cancer Institute's Cancer Nanotechnology Platform Partnerships, heads the research effort that is aiming to use nanotechnology to make photodynamic therapy safer and more effective. His group has approached this problem by using porous silica nanoparticles modified in such a way as to form a strong chemical bond between the nanoparticles and the photosensitizer molecules. When exposed to light, the permanently entrapped photosensitizer still produces reactive oxygen molecules that can diffuse out of the nanoparticles through their porous silica shells.

The investigators found, too, that human colon cancer cells readily take up the photosensitizer-loaded nanoparticles. More importantly, shining light on these cells resulted in their death. In contrast, cells that were not exposed first to these nanoparticles suffered no ill effects from exposure to light. The investigators, who published their results in the journal Nano Letters, note that they are now developing a second-generation nanoparticle-photosensitizer construct that also includes tumor-targeting and imaging molecules.

This work, which was supported by the National Cancer Institute's Alliance for Nanotechnology in Cancer, is detailed in the paper, "Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer." Investigators from the Roswell Park Cancer Institute also participated in this study.

This paper was published online in advance of print publication. An abstract is available through PubMed.

Source: National Cancer Institute

Explore further: Scientist designs lamp light operative photodynamic molecules for tumor therapy

Related Stories

Polymer Nanoparticle Kills Tumors

January 12, 2006

Photodynamic therapy (PDT), which uses a light-sensitive chemical known as a photosensitizer to produce cell-killing “reactive oxygen,” has become an important option for the treatment of esophageal cancer and non-small ...

Physicists create new nanoparticle for cancer therapy

April 16, 2014

A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy.

Nanoparticle drug cocktail could help treat lethal cancers

September 16, 2016

Cancer treatments that mobilize the body's immune system to fight the disease have generated a lot of excitement in the past few years. One form of immunotherapy called checkpoint blockade is especially promising. But while ...

Combining magnetism and light to fight cancer

April 1, 2015

By combining, in a liposome, magnetic nanoparticles and photosensitizers that are simultaneously and remotely activated by external physical stimuli (a magnetic field and light), scientists at the Laboratoire Matière et ...

Recommended for you

Graphene photodetector enhanced by fractal golden 'snowflake'

January 16, 2017

(Phys.org)—Researchers have found that a snowflake-like fractal design, in which the same pattern repeats at smaller and smaller scales, can increase graphene's inherently low optical absorption. The results lead to graphene ...

Nanoscale view of energy storage

January 16, 2017

In a lab 18 feet below the Engineering Quad of Stanford University, researchers in the Dionne lab camped out with one of the most advanced microscopes in the world to capture an unimaginably small reaction.

Scientists create first 2-D electride

January 11, 2017

(Phys.org)—Researchers have brought electrides into the nanoregime by synthesizing the first 2D electride material. Electrides are ionic compounds, which are made of negative and positive ions. But in electrides, the negative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.